Weight Insight is not affiliated with or endorsed by the FDA, MedlinePlus, NIDDK, Novo Nordisk or the organizations referenced above.
Recent anecdotal reports suggest that glucagon-like peptide-1 receptor agonists, such as semaglutide, may reduce food noise
Check Nooms safety information for additional guidance
Approved in 2022 for diabetes (brand Mounjaro), tirzepatide produced extraordinary results in weight loss up to ~22% in obese participants at the highest dose in a phase 3 trial ( [137] )
Clinic Practices That Improve Comfort and Results Providers reduce side effects by slow titration, offer anti-nausea strategies when needed, and pair medication with nutrition and exercise coaching
Same-day or next-day evaluation is appropriate for signs suggesting injection site infection (cellulitis or abscess formation)